Helin Xu
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 36
- Nanoparticle-Based Drug Delivery 20
- Electrospun Nanofibers in Biomedical Applications 8
-
- RNA Interference and Gene Delivery 7
- Co-authors
- Ying‐Zheng Zhao (63 shared papers)Qing Yao (32 shared papers)Jian Xiao (24 shared papers)Deli Zhuge (23 shared papers)Meng‐Qi Tong (19 shared papers)Longfa Kou (11 shared papers)Bi‐Xin Shen (12 shared papers)Cui‐Tao Lu (18 shared papers)
- Journals
- Journal of Controlled Release (8 papers)Acta Biomaterialia (7 papers)International Journal of Pharmaceutics (5 papers)Artificial Cells Nanomedicine and Biotechnology (5 papers)Colloids and Surfaces B Biointerfaces (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Helin Xu
105 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 138
- Biomaterials 1.2k
- Pharmaceutical Science 387
- Molecular Medicine 252
- Rehabilitation 300
- Biomedical Engineering 1.0k
Countries citing papers authored by Helin Xu
This map shows the geographic impact of Helin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helin Xu more than expected).
Fields of papers citing papers by Helin Xu
This network shows the impact of papers produced by Helin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helin Xu. The network helps show where Helin Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Helin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 136 | |
| 2 | 2014 | 135 | |
| 3 | 2017 | 126 | |
| 4 | 2017 | 116 | |
| 5 | 2016 | 88 | |
| 6 | 2018 | 86 | |
| 7 | 2020 | 83 | |
| 8 | 2018 | 82 | |
| 9 | 2015 | 80 | |
| 10 | 2018 | 77 | |
| 11 | 2017 | 69 | |
| 12 | 2015 | 69 | |
| 13 | 2020 | 68 | |
| 14 | 2016 | 68 | |
| 15 | 2022 | 63 | |
| 16 | 2016 | 62 | |
| 17 | 2017 | 62 | |
| 18 | 2019 | 60 | |
| 19 | 2021 | 59 | |
| 20 | 2023 | 58 |
About Helin Xu
Helin Xu is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Surgery and Pharmaceutical Science, having authored 112 papers that have together received 3.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (20 papers), Nanoplatforms for cancer theranostics (13 papers), Advanced Drug Delivery Systems (12 papers), Wound Healing and Treatments (10 papers), Electrospun Nanofibers in Biomedical Applications (8 papers), Tissue Engineering and Regenerative Medicine (8 papers), Inflammatory Bowel Disease (8 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Biomaterials (1.2k citations), Pharmaceutical Science (387 citations), Molecular Medicine (252 citations), Rehabilitation (300 citations) and Biomedical Engineering (1.0k citations). Helin Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ying‐Zheng Zhao, Qing Yao, Jian Xiao, Deli Zhuge, Meng‐Qi Tong, Longfa Kou, Bi‐Xin Shen, Cui‐Tao Lu, Binghui Jin and Xing Tang. Their work appears in journals such as Journal of Controlled Release, Acta Biomaterialia, International Journal of Pharmaceutics, Artificial Cells Nanomedicine and Biotechnology and Colloids and Surfaces B Biointerfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.